Attention Bias Modification for Anxiety in Childhood Cancer Survivors
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
Research shows that Attention Bias Modification (ABM) can help reduce anxiety in children by training them to focus away from negative or threatening information. Studies have found that children who underwent ABM experienced significant decreases in anxiety symptoms, and many no longer met the criteria for anxiety disorders after treatment.
12345Research on Attention Bias Modification (ABM) in children with anxiety shows it is generally safe and well-tolerated. Studies found that children and their parents found the program acceptable, and no safety concerns were reported.
12367Attention Bias Modification (ABM) is unique because it focuses on training children to shift their attention away from threatening information and towards positive stimuli, using computer-based tasks. This approach is different from traditional therapies as it directly targets the underlying attention patterns associated with anxiety, rather than just addressing symptoms.
12348Eligibility Criteria
This trial is for adolescent and young adult cancer survivors who have experienced anxiety after battling childhood cancer, head and neck cancers, or leukemia. Participants should be comfortable using internet-based applications and willing to engage in interviews and questionnaires.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in ABM or inert attention task sessions over 10 minutes twice a week and respond daily to text messaging prompts for 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants are given access to all components of ABM and texts on study after completion of the follow-up survey